Your browser doesn't support javascript.
loading
Cohort profile: radiotherapy dataset (RTDS) in England.
Sandhu, Sabrina; Sharpe, Michael; Findlay, Úna; Roe, Catherine; Broggio, John; Spencer, Katie; Thackray, Katherine.
Afiliación
  • Sandhu S; National Disease Registration Service (NDRS), NHS England, Leeds, UK sabrinasandhu@nhs.net.
  • Sharpe M; National Disease Registration Service (NDRS), NHS England, Leeds, UK.
  • Findlay Ú; National Disease Registration Service (NDRS), NHS England, Leeds, UK.
  • Roe C; Medical Exposures Group, UKHSA, Chilton, UK.
  • Broggio J; National Disease Registration Service (NDRS), NHS England, Leeds, UK.
  • Spencer K; National Disease Registration Service (NDRS), NHS England, Leeds, UK.
  • Thackray K; National Disease Registration Service (NDRS), NHS England, Leeds, UK.
BMJ Open ; 13(6): e070699, 2023 06 20.
Article en En | MEDLINE | ID: mdl-37339842
PURPOSE: The purpose of the Radiotherapy Dataset (RTDS) is to collect consistent and comparable data across all providers of National Health Service (NHS)-funded radiotherapy and to provide intelligence for service planning, commissioning, clinical practice and research. PARTICIPANTS: The RTDS is a mandated dataset requiring providers to collect and submit data monthly for patients treated in England. Data is available from 01 April 2009 to 2 months behind the calendar month.The National Disease Registration Service (NDRS) started receiving data from 01 April 2016. Prior to this, the National Clinical Analysis and Specialised Applications Team (NATCANSAT) were responsible for the RTDS. NDRS holds a copy of the NATCANSAT data for English NHS providers.The RTDS contains clinical information on the primary disease being treated, modality and intent of treatment, dose fractionation and hospital appointment details. Due to constraints in RTDS coding, linkage to the English National Cancer Registration dataset is beneficial. FINDINGS TO DATE: The RTDS has been linked to the English National Cancer Registration and Systemic Anti-Cancer Therapy (SACT) datasets and to Hospital Episode Statistics (HES) to provide a more complete picture of the patient cancer pathway. Findings include a study to compare outcomes for patients treated with radical radiotherapy, an investigation of factors influencing 30-day mortality, assessing sociodemographic variation in the use of treatment and a study to assess the service impact of the COVID-19 pandemic. A range of other studies have been completed or are ongoing currently. FUTURE PLANS: The RTDS can be used for a variety of functions including cancer epidemiological studies to investigate inequalities in treatment access; provide service planning intelligence; monitor clinical practice; and support clinical trial design and recruitment. Collection is to continue indefinitely, with regular updates to the data specification to enable capture of more detailed information on radiotherapy planning and delivery.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article